NCT04624334

Brief Summary

The current diagnostic process of colonic motility disorders often takes a long time and involves multiple invasive, painful and/or unnecessary diagnostic procedures. To improve this diagnostic process, the potential of Electro-Entero-Graphy (EEnG) is investigated. During the EEnG procedure, several surface electrodes are positioned (under ultrasound guidance) on the abdomen so that electrical activity originating in the colon can be measured. Measurements will be performed after a period of fasting (when the colon is 'silent') and just after a meal (when the colon is moving) in both participants suffering from colonic motility disorders and healthy controls. It is hypothesized that these measurements are an indication of colonic motility and can be used as a diagnostic tool for colonic motility disorders. It is also hypothesized that this EEnG procedure is not more burdensome than the Gold Standard procedures for diagnosing colonic motility disorders. This will be assessed using questionnaires.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 10, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

February 25, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2022

Completed
Last Updated

May 19, 2022

Status Verified

April 1, 2022

Enrollment Period

1.2 years

First QC Date

October 29, 2020

Last Update Submit

May 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Power Percent Difference

    Relative power change when comparing pre-prandial EEnG measurements to post-prandial measurements. Power will be calculated as the mean amplitude (mV\^2/Hz) in a bandwidth of 2 cycles per minute around the dominant frequency related to colonic movements (between 2-10 cycles per minute).

    During EEnG procedure

Secondary Outcomes (2)

  • EEnG questionnaire score

    Directly after EEnG procedure, which is a one time procedure the subjects in this study will undergo

  • Gold Standard questionnaire score

    Directly after EEnG procedure, which is a one time procedure the subjects in this study will undergo, or directly after the gold standard procedure, which some subjects will undergo in the near future at time of inclusion

Study Arms (4)

Children with motility disorder

Other: Elektro-Entero-Graphy procedureOther: EEnG QuestionnaireOther: Gold Standard Questionnaire

Healthy children

Other: Elektro-Entero-Graphy procedureOther: EEnG Questionnaire

Adults with motility disorder

Other: Elektro-Entero-Graphy procedureOther: EEnG QuestionnaireOther: Gold Standard Questionnaire

Healthy adults

Other: Elektro-Entero-Graphy procedureOther: EEnG Questionnaire

Interventions

Fasting, after which pre- and postprandial EEnG measurements are performed.

Adults with motility disorderChildren with motility disorderHealthy adultsHealthy children

Filling out questionnaire about EEnG procedure.

Adults with motility disorderChildren with motility disorderHealthy adultsHealthy children

Filling out questionnaire about Gold Standard diagnostic used to diagnose colonic motility disorder.

Adults with motility disorderChildren with motility disorder

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All subjects fulfilling the in- and exclusion criteria will be included. Participants with (suspected) motility disorder will be recruited mainly in the Radboudumc and with the help from the Hirschsprung's patient association.

You may qualify if:

  • All participants:
  • Age ≤ 11 years for babies and children
  • Age ≥ 18 years for adults.
  • Patients
  • For babies/children:
  • suffering from surgically untreated HSCR as determined by a rectal biopsy, or
  • suspected of HSCR, for which a rectal biopsy is planned
  • For adults: Suffering from a (suspected,) surgically untreated functional colonic motility disorder (such as slow-transit constipation, idiopathic/therapy resistant constipation of the colon), as diagnosed previously or will be diagnosed in the near future using the gold standard method.

You may not qualify if:

  • All participants:
  • For adults: BMI \> 27 kg/m2
  • For babies/children: weight for length \> 2.5 standard deviations of WHO Child Growth Standard
  • Pregnancy
  • Diabetes
  • Any food intolerance
  • Presence of an intestinal stoma
  • Use of continuous tube feeding
  • Healthy controls:
  • The presence of any known gastro-intestinal conditions
  • Use of laxatives in the past two years
  • Participants with (suspected) motility disorder:
  • (Part of) colon removed
  • Inflammatory bowel disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboudumc

Nijmegen, Gelderland, 6525 GA, Netherlands

Location

MeSH Terms

Conditions

Colonic DiseasesHirschsprung Disease

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesDigestive System AbnormalitiesMegacolonCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • S.M.B.I. Botden, MD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2020

First Posted

November 10, 2020

Study Start

February 25, 2021

Primary Completion

May 12, 2022

Study Completion

May 12, 2022

Last Updated

May 19, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

IPD will be available to other researchers on reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After publication of the results.
Access Criteria
Upon reasonable request via e-mail.

Locations